'Lancet report on India COVID-19 response another attempt to undermine developing country's ability to challenge big pharma's monopoly'
May 13, 2021
Brussels [Belgium], May 13 : Medical journal Lancet's latest report on COVID-19 situation in India that discusses the Indian government's management of the pandemic is yet another attempt by the big pharma lobby to undermine the "abilities of a developing country to challenge their monopoly by rolling out vaccines at throwaway prices," according to a report in EUreporter.